1,479 companies

Eli Lilly

Market Cap: US$730.6b

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.

LLY

US$824.76

7D

-0.6%

1Y

8.1%

Johnson & Johnson

Market Cap: US$392.0b

Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.

JNJ

US$162.84

7D

-2.9%

1Y

3.9%

AbbVie

Market Cap: US$373.8b

A research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide.

ABBV

US$214.47

7D

-1.0%

1Y

20.2%

Novo Nordisk

Market Cap: DKK 2.4t

Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.

NOVO B

DKK 545.20

7D

-0.8%

1Y

-40.4%

Roche Holding

Market Cap: CHF 249.2b

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.

ROG

CHF 311.10

7D

1.2%

1Y

35.5%

AstraZeneca

Market Cap: UK£184.6b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

AZN

UK£119.04

7D

0.5%

1Y

15.7%

Merck

Market Cap: US$238.9b

Operates as a healthcare company worldwide.

MRK

US$94.79

7D

-0.5%

1Y

-21.9%

Novartis

Market Cap: CHF 194.7b

Engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally.

NOVN

CHF 98.60

7D

-2.7%

1Y

15.3%

Thermo Fisher Scientific

Market Cap: US$196.9b

Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.

TMO

US$519.57

7D

-1.4%

1Y

-10.4%

Amgen

Market Cap: US$168.5b

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.

AMGN

US$317.17

7D

-3.1%

1Y

17.1%

Danaher

Market Cap: US$150.6b

Designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.

DHR

US$212.60

7D

3.6%

1Y

-15.5%

Sanofi

Market Cap: €134.8b

A healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally.

SAN

€107.52

7D

-1.8%

1Y

22.2%

Pfizer

Market Cap: US$145.8b

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.

PFE

US$26.05

7D

-2.2%

1Y

-6.0%

Gilead Sciences

Market Cap: US$138.8b

A biopharmaceutical company, discovers, develops, and commercializes medicines for virology, oncology and other therapeutic areas in the United States, Europe, and internationally.

GILD

US$112.26

7D

-4.2%

1Y

53.2%

Vertex Pharmaceuticals

Market Cap: US$129.6b

A biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).

VRTX

US$513.76

7D

2.7%

1Y

24.9%

Bristol-Myers Squibb

Market Cap: US$119.7b

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

BMY

US$59.99

7D

-4.9%

1Y

16.3%

GSK

Market Cap: UK£62.6b

Engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

GSK

UK£15.36

7D

-1.4%

1Y

-7.5%

CSL

Market Cap: AU$120.0b

Researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.

CSL

AU$247.69

7D

-1.7%

1Y

-11.3%

Chugai Pharmaceutical

Market Cap: JP¥11.3t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

4519

JP¥6,832.00

7D

0.7%

1Y

12.7%

Zoetis

Market Cap: US$72.2b

Engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally.

ZTS

US$165.17

7D

-3.9%

1Y

-3.2%

Regeneron Pharmaceuticals

Market Cap: US$71.4b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.

REGN

US$678.42

7D

-8.9%

1Y

-29.3%

Merck KGaA

Market Cap: €59.2b

Operates as a science and technology company in Germany.

MRK

€136.05

7D

1.1%

1Y

-13.0%

Takeda Pharmaceutical

Market Cap: JP¥7.1t

Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.

4502

JP¥4,512.00

7D

1.4%

1Y

3.1%

Sun Pharmaceutical Industries

Market Cap: ₹4.1t

A generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally.

SUNPHARMA

₹1,704.30

7D

5.8%

1Y

8.5%

Haleon

Market Cap: UK£35.5b

Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.

HLN

UK£3.92

7D

-1.4%

1Y

24.5%

Daiichi Sankyo Company

Market Cap: JP¥6.6t

Manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally.

4568

JP¥3,539.00

7D

2.2%

1Y

-27.6%

Jiangsu Hengrui Medicine

Market Cap: CN¥295.5b

A pharmaceutical company, researches, develops, manufactures, and commercializes drugs in China and internationally.

600276

CN¥46.48

7D

2.2%

1Y

-1.7%

UCB

Market Cap: €35.1b

A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.

UCB

€184.95

7D

9.2%

1Y

72.0%

argenx

Market Cap: €34.0b

A biotechnology company, engages in the developing of various therapies for the treatment of autoimmune diseases in the United States, Japan, Europe, Middle East, Africa, and China.

ARGX

€560.20

7D

5.5%

1Y

68.1%

Agilent Technologies

Market Cap: US$34.5b

Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.

A

US$122.49

7D

0.5%

1Y

-16.2%

Alnylam Pharmaceuticals

Market Cap: US$31.3b

Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.

ALNY

US$253.11

7D

8.6%

1Y

71.7%

BeiGene

Market Cap: US$28.4b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

ONC

US$265.07

7D

7.9%

1Y

57.7%

Celltrion

Market Cap: ₩40.3t

Develops and produces drugs based on proteins for the treatment of oncology in South Korea.

A068270

₩187,400.00

7D

2.2%

1Y

6.7%

Otsuka Holdings

Market Cap: JP¥4.1t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

4578

JP¥7,848.00

7D

4.5%

1Y

24.1%

Mettler-Toledo International

Market Cap: US$25.7b

Manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally.

MTD

US$1,235.02

7D

-4.6%

1Y

-5.4%

Bayer

Market Cap: €23.4b

Operates as a life science company worldwide.

BAYN

€23.79

7D

1.0%

1Y

-9.3%

Page 1 of 42